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Abbreviations: 
TGFβ1-Transforming Growth Factor 
beta 1  
MAPK-Mitogen Activated Protein 
Kinase 
EMT-Epithelial to Mesenchymal 
Transition 
pAkt T308- Phosphorylated Akt at 
Threonine 308  
pAkt S473-Phosphorylated Akt at Serine 
473  
OSCC- Oral Squamous Cell Carcinoma 
HNSCC- Head and Neck Squamous Cell 
Carcinoma 
 
A B S T R A C T 
Introduction: TGFβ1 activates both SMAD and non-SMAD dependent signalling pathways but their role 
in oral cancer cell migration and metastasis is little known. The aim of this research was to investigate the 
role of TGFβ1-induced signalling pathways in oral cancer cell migration and to establish whether the 
inhibition of the associated pathway may be a suitable target for chemotherapeutic drug design to control 
oral cancer cell metastasis. 
Materials and Methods: SDS-PAGE and Western blot techniques were used to investigate the expression 
and phosphorylation status of TGFβ1- induced key signalling molecules such as, SMAD, Akt and MAPK 
in normal keratinocytes and oral cancer cells. Gap closure and scatter assays were employed to study the 
effect of TGFβ1 on cell migration. Akt and MAPK inhibitors were also used to explore the role of associated 
signalling pathways in TGFβ1-induced cell migration. Phosphorylation of Akt, MAPK and SMAD were 
analysed by immunofluorescence in TGFβ1-induced migrated cells. 
Results: TGFβ1 stimulated the phosphorylation of SMAD, Akt and MAPK in both normal keratinocytes 
and oral cancer cells. The level of phosphorylation, however, depended upon cell type, time of exposure to 
and concentration of TGFβ1. TGFβ1-stimulated cancer cell migration both as single cells (EMT, epithelial 
to mesenchymal transition) and as a sheet of cells.  Inhibitor assays confirmed that cancer cell migration is 
phosphorylated-Akt dependent. However, TGFβ1 did not stimulate migration as a sheet of cells, but EMT 
of normal keratinocytes which was phosphorylated-MAPK dependent. 
Conclusion: TGFβ1-induced oral cancer cell migration was dependent on the Akt signalling pathway. From 
this study, we propose that blocking the Akt pathway may inhibit oral cancer metastasis and could have 
potential in translating this research into clinical practice. 
 
 
 
 
 
                                   © 2018 Dr Mohammad R Islam. Hosting by Science Repository. All rights reserved.    
Introduction 
Head and neck cancer are the sixth most common cancer in the world 
and squamous cell carcinoma is the most predominant. Oral cancer is a 
type of head and neck cancer which includes cancers of the lips, tongue, 
cheeks, floor of the mouth, hard and soft palate, sinuses, and pharynx 
(throat). While oral cancer patients have a 5-year survival rate below 
40%, patients with metastatic disease have an extremely poor prognosis 
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and a survival rate lower than 10% [1, 2].The development of distant 
metastases, second primary tumours and potentially inoperable 
recurrences with increased resistance to radiation or chemotherapy are 
the main reasons for mortality [3]. Cell motility or migration is an 
essential part of most tumour metastatic and wound healing pathways. 
Cells need to migrate away from their microenvironment to enable the 
tumour to spread or metastasise. Cell migration can be divided into 
collective (migration as a group/sheet of cells without completely 
disrupting their cell-cell contacts) and single cell migration [4, 5]. Most 
of the single cell migration is accomplished by epithelial to 
mesenchymal transition (EMT) which is an important biological 
phenomenon characterised by changes in morphology from cuboidal 
epithelial to spindle shape mesenchymal, overexpression of vimentin (a 
mesenchymal marker) and loss of E-cadherin (an epithelial marker) [6].  
 
Earlier evidence suggested that, growth factors and matrix 
macromolecules are essential for the movement of cells [7]. Previous 
studies in our laboratories showed that Vascular Endothelial Growth 
Factor (VEGF), Epidermal Growth Factor (EGF) and Transforming 
Growth Factor alpha (TGFα) stimulate both fibroblast and oral cancer 
cells to migrate. We have previously shown that the PI3 kinase/Akt 
pathways are essential for the migration of fibroblasts and oral cancer 
cells in response to added factors. The addition of PI3 kinase/Akt 
inhibitors block the migration stimulating activity of VEGF, EGF and 
TGFα, the data indicating that those growth factors increase 
phosphorylation of Akt at Thr 308 and Ser 473 [8-10]. The role of 
TGFβ1, however, is still unknown in oral cancer cell metastasis. In 
contrast to its tumour suppressive effect, TGFβ signalling also promotes 
tumour progression by means of loss of epithelial cell adhesion, 
extracellular matrix remodelling and enhanced angiogenesis [11].  A 
study using cancer tissues reported that TGFβ1 was overexpressed in 
36% of oesophageal cancer [12]. Pasini et al (2001) also reported 
increased levels of TGFβ1 mRNA levels in HNSCC [13]. Interestingly, 
the percentage of TGFβ1 overexpression in oral cancer being the highest 
(66%) among tumours from different sites of HNSCC [14]. 
Approximately 78% of HNSCC samples also exhibited a 1.5- to 7.5-fold 
increase in TGFβ in comparison with normal controls [14]. TGF-β 
initiates Smad as well as non-Smad dependent signalling, such as 
PI3K/Akt, P44/42 MAPK (Erk1/2), p38 MAPK, and Rho-GTPase 
pathways [15, 16]. TGF-β acts as a common and potent inducer of EMT 
by combining both Smad and non-Smad signalling pathways [17-19].  
 
In this study we aimed to investigate the role of downstream signalling 
pathways in TGFβ1-induced oral cancer cell migration. The resultant 
data increases the spectrum of knowledge of the TGFβ induced pathways 
and to propose that inhibition of pathway would be a suitable target for 
chemotherapeutic drug design to control oral cancer cell metastases. 
 
Materials and Methods 
 
I Reagents, antibodies and inhibitors 
 
The primary antibodies used were: rabbit monoclonal anti-pAkt T308 (# 
2965), anti-pAkt S473 (# 4060), anti-pan Akt (# 4691), anti-SMAD2/3 
(#8685), anti-p-SMAD2/3 (# 8828), anti-P44/42 MAPK (# 9102), anti- 
phospho P44/42 MAPK (#4370), anti- E-cadherin (# 3195) and anti-
Vimentin (# 3932) (all Cell Signaling Technology, Inc., Danvers, MA, 
USA). The secondary antibodies used were goat anti-rabbit HRP 
conjugated (# 7074, Cell Signaling Technology), and goat anti-rabbit 
alexa fluor 488 conjugated (# 4412, Cell Signaling Technology). 
Recombinant Human TGFβ1 (# 77039) was purchased from Sigma, St. 
Lous, MO, USA. The PI3K-Akt pathway inhibitors MK2206 (# S1078) 
was purchased from Seleckchem, Houston, USA and MAPK inhibitor, 
PD98059 (#9900) was purchased from Cell Signaling Technology. 
 
II Cell culture 
 
The oral squamous cell carcinoma (OSCC) cell line (TYS), derived from 
floor of the mouth was a kind gift from Dr. Koji Harada, University of 
Tokushima, Japan. Normal adult keratinocytes (HaCaT) were a kind gift 
from Professor S.L. Schor (late), Dundee Dental School, UK. All cells 
were cultured at 37°C and 5% CO2 in minimum essential medium 
(MEM) supplemented with 10% (v/v) heat-inactivated foetal calf serum 
and 200 mM glutamine. 
 
III Cell lysis, SDS-PAGE and Western blot 
 
60-70 % confluent cells were treated with the experimental conditions 
(TGFβ1 ± inhibitors) for a maximum 48 hours and serum starved 
overnight. Cells were then lysed on ice with RIPA buffer (50 mM Tris 
HCl, 150 mM NaCl, pH 7.4; 0.1% w/v SDS, 1% v/v Triton x-100, 1% 
w/v sodium deoxycholate and 5 mM EDTA) containing protease 
inhibitors (Roche Applied Science, IN, USA) at different time points. 
Lysates were clarified by centrifugation at 13,000 rpm for 5 minutes. 
Samples were then mixed with an equal volume of Laemmli sample 
loading buffer (BioRAD, CA, USA) including 5% (v/v) 2-
mercaptoethanol. Samples were heated at 95 °C for 5 minutes and 
loaded onto either 10% or ‘Any kD’ SDS-PAGE BioRad stain-free 
precast gels. After completion of SDS PAGE, gel images were captured 
using Gel Doc imaging system (BioRad) for total protein and were then 
electro-transferred onto PVDF transfer membrane (BioRad). Blots were 
then immunolabelled with anti-pAkt T308 (1:1000), anti-pAkt S473 
(1:2000), anti-pan Akt (1:1000), anti- SMAD2/3(1:1000), anti-pSMAD 
2/3 (1:1500), anti-P44/42 MAPK (ERK1/2) (1:1000) and anti-phospho 
P44/42 MAPK (pERK1/2) (1:2000) and  goat anti-rabbit HRP 
conjugated secondary antibody (1:2000). Immunoblots were developed 
using Immun-Star WesternC Kit (BioRad) and images were captured 
using a Gel Doc imaging system. Total protein gel images were used to 
normalise and quantify the respective blot by Image lab software 
(BioRad) instead of housekeeping gene such as GAPDH. Images were 
then cropped and processed using ImageJ software (NIH, Bathesda, 
USA). 
 
IV Scatter assay and immunofluorescent staining 
 
Cell scattering is a dynamic process for investigating EMT in which 
dispersion of compact colonies of epithelial cells is induced by certain 
soluble factors such as growth factors [20]. The assay was performed as 
described earlier [10]. In brief, cells were seeded at a density of 2 × 104 
cells/ml, in 60 mm dishes and grown until small well-defined colonies 
were visible. The cells were washed twice, serum starved overnight, and 
incubated in test conditions for 48 hours. Scattering of the cells was 
observed by at least two individuals before images were taken. Images 
were captured using SC50 digital camera attached to inverted  
microscope (IX70, Olympus, Tokyo, Japan) at either 100X or 200X 
magnification. 
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After 48 hours, the cells were fixed with cold methanol for 15 minutes 
and then washed with phosphate-buffered saline (PBS). Cells were then 
treated with 0.2% (v/v) Triton X-100 in PBS for 5 minutes, small areas 
of the dishes were ringed with Immunopen (DAKO, Cambridgeshire, 
UK) and blocked with 5% (v/v) normal goat serum (NGS; Vector 
Laboratories, Burlingame, CA, USA) in PBS with 0.1% (v/v) Tween 20 
(PBST) for 30 minutes. The cells were then incubated with anti-E-
cadherin (1:200), anti-vimentin (1:50), anti-pAkt T308 (1:1600 #13038, 
Cell Signaling Technology), anti-pAkt S473(1:200), anti-P44/42 MAPK 
(1:100), anti- phospho P44/42 MAPK (1:200) rabbit monoclonal 
primary antibodies diluted in 5% (v/v) NGS in PBST and kept at 4°C for 
overnight. They were then washed twice with PBST, once with PBS and 
incubated with anti-rabbit immunoglobulin G (H+L), F(ab′)2 Fragment 
(Alexa Fluor® 488 Conjugate) (1:1000) for 1 hour at room temperature. 
After washing twice with PBST and once with PBS, sections were cover 
slipped with aqueous mounting medium (Sigma-Aldrich, St Louis, MO, 
USA). Sections were then viewed with an Olympus IX70 inverted 
fluorescent microscope (Olympus, Tokyo, Japan) at 200X or 400X 
magnification. Images were captured using a XM10 digital camera 
(Olympus). All devices were controlled, and images were processed by 
CellSense software (Olympus). 
 
V Scratch assay 
 
The scratch assay, a directional in vitro 2D migration assay, was 
performed as described earlier [21]. A cell monolayer was serum starved 
overnight and then a wound was made in the monolayer using a 100μl 
pipette tip. The cells were then incubated in test conditions (TGFβ1 ± 
MK2206) for 24 hours. Images were captured using an IX70 inverted 
microscope start at t=0 and at the end point to monitor cell migration 
causing wound closure. Scratch images were then quantified using 
ImageJ macros-MRI wound healing tool. 
 
VI Modified gap closure assay 
 
A cell culture inserts (#81176, IBIDI GmbH, Munich, Germany) was 
used to modify the traditional gap closure/wound healing/scratch assay. 
Instead of making a scratch in a cell monolayer where cells are wounded, 
a culture insert was used to create a cell-free gap. Two cell culture 
reservoirs in the insert allowed cell growth in the designated areas after 
filling them with the cell suspension. The culture insert was removed 
after 24 hours of cell attachment which created a cell-free gap of 
approximately 500 µm. Test conditions (TGFβ1 ± MK2206) were then 
applied and incubated for 24 hours. Images were captured using an 
inverted microscope at the start and end of the experiment at 100X 
magnification and quantified using ImageJ macros-MRI wound healing 
tool. 
 
VII Statistical Analysis 
 
The data was analysed by Graphpad Prism (v5.0) (La Jolla, CA, USA). 
All the experiments were repeated at least three times. Differences 
between groups were evaluated with the Student's t-test. Differences 
were considered significant when the p value was less than 0.05. 
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Figure 1: TGFβ1 stimulated non-SMAD pathways which was time and concentration dependent. (A) Normal keratinocytes and (C) oral cancer cells were 
incubated with different concentrations of TGFβ1 for a maximum of 48 hours and lysed at different time points. Lysates were then analysed by SDS-APGE 
and WB experiments for pAkt T308, pAkt S473 and pan Akt antibodies. (B) Percent changes in pAkt level in HaCaT cells and (D) in oral cancer cells. Blot 
images were normalised against total protein and quantified using ImageLab software. All the experimental conditions were compared with the control (SF-
serum free medium at 30 minutes). (E) P44/42 MAPK and phospho-P44/42 MAPK antibodies were also applied in 10 ng/ml TGFβ1 treated cell lysates. 
Bands were observed at 42 and 44 kDa. (F) Quantification of the level of changes in total MAPK and phosphorylated MAPK in response to TGFβ1 at 
different times (G) Cells were treated with 5µM MK2206 and 50µM PD98059 with or without 10ng/ml TGFβ1 for 24 hours. Cell lysates were then analysed 
by SDS-APGE and WB experiments for p-MAPK, pAkt S473 and pAkt T308 antibodies. All the images were cropped from the original blot images. SF 
(serum-free MEM medium) used as a negative control. (*) denotes to p<0.05. 
 
Results 
 
I TGFβ1 triggered both SMAD and non-SMAD dependent 
pathways which was time dependent 
 
Normal adult keratinocytes and oral cancer cells were treated with 
different concentrations TGFβ1 for 48 hours and both cells 
phosphorylated Akt at Ser473 and Thr 308 residues, but the level of 
phosphorylation was different. TGFβ1 (10 ng/ml) increased the 
phosphorylation of Akt at S473 to a level approximately 9-fold in HaCaT 
cells (p<0.05) (Figure 1A, 1B) and more than 2-fold in TYS cells than 
the control after 48 hours (p<0.05) (Figure 1C, 1D). TGFβ1 also 
increased the phosphorylation of Akt at T308 approximately 11-fold in 
HaCaT (p<0.05) (Figure 1A, 1B) and 2-fold in TYS cells than the control 
after 24 hours (p<0.05) and the level decreased to lower than control 
(TYS) (Figure 1C, 1D) and back to control levels (HaCaT) after 48 hours 
(Figure 1A,1B). The amount of Pan Akt was consistent in both cell lines 
treated with different concentrations of TGFβ1 for 48 hours (Figure 1A, 
1C). TGFβ1 also increased the phosphorylation of MAPK in HaCaT 
cells about 6-fold and about 1.5-fold in TYS than that of control after 48 
hours (Figure 1E, 1F). The level of MAPK expression was consistent in 
both cell lines (Figure 1E, 1F).  The Akt inhibitor (MK2206) and MAPK 
inhibitor (PD98059) effectively blocked the phosphorylation of Akt and 
MAPK respectively, in normal keratinocytes. MK2206 effectively 
blocked TGFβ1-induced Akt phosphorylation in oral cancer cells but 
PD98059 blocked the phosphorylation of MAPK only in 44 kDa isoform 
or ERK1 (Figure 1G). Cells treated with 10 ng/ml TGFβ1 for 24 hours 
showed that total SMAD2/3 expression was not changed compared to 
that of control. TGFβ1 also stimulated the phosphorylation of SMAD2/3 
5 times higher in HaCaT (p<0.05) and more than 2 times higher in TYS 
than the control after 2 hours (p<0.05) and the level of phosphorylation 
went down after 4 hours in both cell lines (Figure 5A, 5B). 
 
II TGFβ1 stimulated the scattering of both cell lines via two 
separate signalling pathways.  
 
Small colonies of normal adult keratinocytes were treated with 10 ng/ml 
TGFβ1 for 48 hours and cells started to scatter out from these colonies 
after 24 hours. After 48 hours, a mesenchymal-type cell morphology was 
observed in the scattered cells. MAPK inhibitor, PD98059, effectively 
blocked the TGFβ1-induced scattering of normal keratinocytes, whereas 
the Akt inhibitor, MK2206, did not block scattering (Figure 2A). Oral 
cancer cells also scattered from colonies as mesenchymal-type cells after 
24 hours and this morphology persisted for 48 hours. Scattering of oral 
cancer cells, however, was effectively blocked by the Akt inhibitor, 
MK2206. MAPK inhibitor, PD98059 could not block the TGFβ1-
induced scattering of oral cancer cells (Figure 2B). 
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Figure 2: (A) TGFβ1-induced normal keratinocyte (HaCaT) scattering/migration is MAPK dependent and (B) oral cancer (TYS) scattering/migration is 
Akt dependent. Cells were treated with 10 ng/ml TGFβ1 alone and/or in combination with 5µM MK2206 and 50µM PD98059 for 48 hours. Cells scattering 
was observed for 48 hours and images were captured at different time points. An inverted microscope with a digital camera was used to capture the images 
at either 100x or 200X magnification. Cells were fixed after 24 hours and 48 hours of observation. SF (serum-free MEM medium) was used as a negative 
control. 
 
III TGFβ1-induced oral cancer cells scattered through EMT 
after 24 hours with strong Akt and MAPK and no SMAD 2/3 
phosphorylation 
 
Cells treated with TGFβ1 for 48 hours showed high levels of vimentin 
expression and low levels of E-cadherin expression, which corroborated 
the idea that the cells scattered as a result of EMT. Serum-free MEM 
treated non-scattered cells showed strong E-cadherin expression at cell-
cell junctions (Figure 3). Phosphorylation of Akt at Ser473 was higher 
in TGFβ1-induced scattered normal keratinocytes (Figure 3) after 24 
hours compared to the control and pAkt T308. Phosphorylated Akt in 
both residues, however, was stronger in the oral cancer scattered cells 
than the serum-free medium treated non-scattered cells (Figure 4). 
Phosphorylation of MAPK, however, was higher in TGFβ1-induced 
scattered oral cancer cells (highest at 24 hours) and in normal 
keratinocytes (highest at 48 hours) compared to cells treated with serum-
free MEM medium (control) (Figure 3 & 4). No phosphorylation of 
SMAD2/3 was observed in TGFβ1-induced scattered oral cancer cells 
after 24 hours, however, a low level of phosphorylation of SMAD2/3 
was observed in scattered normal keratinocytes after 24 hours. A low-
level phosphorylation of SMAD2/3 was observed after 2 hours of 
TGFβ1 treatment in oral cancer cells compared to the control (Figure 
5C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: TGFβ1-induced normal keratinocytes (HaCaT) scattered through EMT. Phosphorylation of both Akt S473, MAPK and vimentin expression were 
visualised by Immunofluorescence using anti-E-cadherin, anti-vimentin, anti-pAkt S473, anti-pAkt T308 and anti-pMAPK antibodies after 48 hours of 
scattering. Images were captured by an inverted fluorescence microscope and CellSense software either at 200x or 400X magnification and processed by 
ImageJ software. SF (serum-free MEM medium) was used as a negative control.  
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Figure 4: TGFβ1-induced oral cancer cell (TYS) scattered through EMT and higher pAkt was observed in scattered cells than the control after 48 hours. 
Fixed scattered cells were labelled with anti-E-cadherin, anti-vimentin, anti-pAkt S473, anti-pAkt T308 and anti-pMAPK antibodies and visualised by an 
Alexa Fluor ® tagged secondary antibody. Images were captured by inverted fluorescence microscope and CellSense software. Images were captured either 
at 200x or 400X magnification and processed by ImageJ software. SF (serum-free MEM medium) was used as a negative control. 
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Figure 5: SMAD phosphorylation was persisted for 2 hours in oral cancer. (A) Cells were incubated by 10 ng/ml TGFβ1 for 24 hours and lysed at different 
time points. SMAD 2/3 and pSMAD2/3 antibodies were then used in WB experiments. (B) Quantification of the level of changes in total SMAD and 
phosphorylated SMAD in response to TGFβ1 at different times. Blot images were normalised against total protein and quantified using ImageLab software. 
All the experimental conditions were compared with the control (SF-serum free medium). (*) denotes to p<0.05. (C) Cells were treated with 10 ng/ml 
TGFβ1 for 24 hours and fixed at different time points. Cells were then labelled with anti-SMAD2/3 and anti-pSMAD2/3 antibodies and visualised by an 
Alexa Fluor ® tagged secondary antibody. Images were captured by an inverted fluorescence microscope and CellSense software. Images were captured 
either at 200x or 400X magnification and processed by ImageJ software.  
 
IV TGFβ1-induced oral cancer cell migration is Akt dependent 
 
TGFβ1 stimulated the migration of oral cancer cells in both traditional 
scratch (Figure 6A) and modified gap closure (Figure 6B) assays. The 
gap created by either scratch or inserts in the oral cancer cell monolayer 
was closed completely after 24 hours by cell migration stimulated by 10 
ng/ml TGFβ1 (p<0.05) (Figure 6A, 6B, 6C). Normal keratinocytes, 
however, were not stimulated to migrate by exogenous TGFβ1 in the 
scratch assay (Figure 6A). MK2206, the Akt inhibitor, blocked about 
60% of TGFβ1-induced cell migration of oral cancer cells (Figure 6A, 
6C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: TGFβ1 stimulated oral cancer cell migration in an Akt-dependent manner in the gap closing assay. (A) Cells were treated with 10 ng/ml TGFβ1 
with or without Akt inhibitor, MK2206 (5 µM) for 24 hours in the scratch/wound healing assay. (B) Oral cancer cells were treated with 10 ng/ml TGFβ1 
with or without the Akt inhibitor, MK2206 (5 µM) for 24 hours in the modified gap closing assay. Images were captured by inverted fluorescence microscope 
and CellSense software at 100x magnification and processed by ImageJ software. SF (serum-free MEM medium) was used as a negative control. (C) 
Quantification of modified gap closure assay. Images were quantified by an ImageJ-macros, MRI wound healing tools. All the experimental conditions were 
compared with the negative control. (*) denotes to p<0.05. 
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Discussion 
 
Protein expression and status of phosphorylation study confirmed that 
TGFβ1 can induce both SMAD-dependent and non-SMAD (PI3K, 
MAPK) dependent signalling pathways. This study showed that TGFβ1 
phosphorylates SMAD2/3, Akt and MAPK in both normal keratinocytes 
and oral cancer cells. The phosphorylation of those signalling proteins 
in response to TGFβ1, was however time dependent. Zi et al (2012) also 
reported in their mathematical modelling study that TGFβ1 signalling is 
time dependent [22]. Phosphorylation of the SMAD2/3 was observed as 
an early event and only persisted for 2 hours in oral cancer cells, whereas 
both Akt and MAPK phosphorylation started as early as 30 minutes after 
stimulation and persisted for 48 hours. Akt phosphorylation at S473 
residue was higher than that of T308 residue in the oral cancer cell line. 
The phosphorylation level of Akt T308 went down after 24 hours, while 
pAkt S473 levels were highest after 48 hours in both normal 
keratinocytes and oral cancer cells suggested that the phosphorylation of 
the two residues in Akt might result in a different biological response. 
Akt phosphorylation at S473 is induced by mTORC2 (mammalian target 
of rapamycin complex 2), but the association between TGFβ1 and 
mTORC2 is unknown [23]. By analysing our results along with the data 
obtained from another study we hypothesise that TGFβ1 can activate the 
PI3K-PDK1 complex that phosphorylates Akt at T308, increasing Akt 
kinase activity. Akt phosphorylates SIN1 at T86, enhancing mTORC2 
kinase activity, which leads to phosphorylation of Akt S473 by 
mTORC2, thereby catalysing full activation of Akt [24].  
 
In this study, wound healing (scratch) and scatter assays were included 
to investigate two different modes of cell migration. The wound healing 
(or scratch) assay is a popular 2-D in vitro assay to visualise collective 
cell migration and the scatter assay is used to visualise single cell 
migration. A modified gap closure assay was also employed in this study 
to avoid making wounds in the cell monolayer and to escape some 
confounding factors such as changes in the strength of cell–cell 
adhesions under different conditions and cell crowding that might affect 
cell migration [25]. Normal keratinocytes and oral cancer cells migrated 
out of cell colonies in response to addition of TGFβ1 as a single cell and 
with mesenchymal-type morphology. A mesenchymal-type cell shape 
with high vimentin and low/no E-cadherin expression further confirmed 
that TGFβ1-induced cell migration was accomplished by EMT. 
However, addition of Akt and MAPK phosphorylation inhibitors 
revealed a rather interesting result in the migration assays. Our data 
indicated that TGFβ1-induced oral cancer cell and normal keratinocyte 
migration through EMT is Akt and MAPK dependent, respectively. 
Previous studies showed that TGFβ1 stimulated both normal 
keratinocytes and oral cancer cell migration through EMT [26-29]. 
Secker et al (2008) also revealed that TGFβ1 stimulation of  HaCaT cell 
migration through EMT is MAPK dependent [30]. A previous study also 
suggested that TGFβ-induced EMT in breast cancer cell was dependent 
on the PI3K/Akt signalling pathway [31]. This is the first report to show 
that TGFβ1-induced oral cancer cell migration is dependent on the Akt 
signalling pathway. This study also suggested that Akt phosphorylation 
played an important role in oral cancer cell migration, by the fact that it 
remained phosphorylated for 48 hours and this corresponded with the 
time for cell migration. On the other hand, the Akt inhibitor effectively 
blocked TGFβ1-induced oral cancer cell migration. Previous studies 
reported that Akt activates Twist, a basic helix-loop-helix transcription 
factor by phosphorylating the Ser16 residue, which induces EMT in 
HNSCC [32-34].  Although, in this study SMAD2/3 and MAPK were 
also phosphorylated in TGFβ1-induced oral cancer cells results indicated 
that these signalling molecules were not involved in cell migration. For 
example, SMAD2/3 phosphorylation persisted for only 2 hours, whereas 
oral cancer cell migration was observed after 24 hours and the MAPK 
inhibitor could not block this migration. This study therefore supports 
the idea that TGFβ1 could induce cell migration during both wound 
healing and cancer metastasis. The mode of cell migration and associated 
signalling cascade, however, largely depends upon the cell types, assay 
format, incubation time and available concentrations of the ligand. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: An extrapolated diagram of the role TGFβ1-induced signalling 
pathways in oral cancer metastasis. Oral cancer cell migration is blocked 
by Akt inhibitor, MK-2206 which indicates oral cancer metastasis is Akt 
signalling pathway dependent. Normal keratinocytes migration, 
however, is dependent on MAPK signalling pathways. SMAD is 
phosphorylated in oral cancer cells but not involved in cell migration. 
 
Conclusion 
 
This study revealed that TGFβ1-induced normal keratinocyte and oral 
cancer cell migration is dependent on two separate non-SMAD 
dependent pathways, namely the MAPK and Akt signalling pathways, 
respectively. The result is summarised in an over simplified view of 
events in Figure 7. This study also suggests that two signalling pathways 
are involved in TGFβ1-induced wound healing (MAPK) and metastasis 
(Akt). Therefore, targeting the Akt signalling pathway to inhibit oral 
cancer metastases would be a potential approach in the clinic in future. 
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